Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy-Reference-Cited by-同舟云学术

Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy

Published:2022-03-28 Issue:11 Volume:37 Page:2733-2742
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Miyaji Mai J.,Ide Kentaro,Takashima Kohei,Maeno Mikiko,Krallman Kelli A.,Lazear Danielle,Goldstein Stuart L.

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00467-022-05502-8.pdf

Reference36 articles.

1. (2012) Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group - KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int suppl 2:1–138

2. Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desai MS, Braun MC, Akcan Arikan A (2017) Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One 12:e0182134

3. Schultheiss C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwachter H, Schmid RM, Huber W (2012) Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 16:R162

4. Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, Chen X (2019) Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care 23:22

5. Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A (2017) Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Crit Care 21:294

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin Resistance after Andexanet Alfa – Calling on Argatroban and Nafamostat for Rescue?;Journal of Cardiothoracic and Vascular Anesthesia;2024-09

2. Factors influencing circuit lifetime in paediatric continuous kidney replacement therapies – results from the EurAKId registry;Pediatric Nephrology;2024-07-18

3. Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy;Scientific Reports;2024-06-12

4. Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study;BMC Nephrology;2024-02-26

5. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses;European Journal of Medicinal Chemistry;2024-02